We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories
RDY

128 hedge funds and large institutions have $1.07B invested in Dr. Reddy's Laboratories in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $1B → $1.07B (+$61M)

0.79% more ownership

Funds ownership: 75.46% → 76.25% (+0.79%)

9% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 46

4% less funds holding

Funds holding: 134 → 128 (-6)

12% less call options, than puts

Call options by funds: $548K | Put options by funds: $623K

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
128
Holders Change
-6
Holders Change %
-4.48%
% of All Funds
3.19%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
42
Reduced
46
Closed
19
Calls
$548K
Puts
$623K
Net Calls
-$75K
Net Calls Change
+$884K

Top Buyers

1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$36.3M
2
Renaissance Technologies
Renaissance Technologies
New York
+$7.09M
3
First Trust Advisors
First Trust Advisors
Illinois
+$6.86M
4
CBOA
Commonwealth Bank of Australia
Australia
+$6.86M
5
Deutsche Bank
Deutsche Bank
Germany
+$4.51M

Top Sellers

1
AQR Capital Management
AQR Capital Management
Connecticut
-$20M
2
AI
Axiom Investors
Connecticut
-$11.1M
3
CS
Credit Suisse
Switzerland
-$7M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$3.12M
5
BlackRock
BlackRock
New York
-$2.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
76
Profund Advisors
Maryland
$499K +$23.6K +2,900 +5%
GC
77
Guggenheim Capital
Illinois
$498K +$80.9K +9,950 +20%
FIM
78
Freedom Investment Management
Connecticut
$469K -$83.8K -10,305 -16%
Ameriprise
79
Ameriprise
Minnesota
$426K +$42.9K +5,270 +12%
WAM
80
World Asset Management
Michigan
$411K -$23.9K -2,945 -6%
LWM
81
Lenox Wealth Management
Ohio
$409K +$395K +48,580 New
LCM
82
Logan Capital Management
Pennsylvania
$386K – – –
AllianceBernstein
83
AllianceBernstein
Tennessee
$383K +$51.9K +6,385 +16%
Comerica Bank
84
Comerica Bank
Texas
$370K -$40.4K -4,965 -10%
LNWWM
85
Laird Norton Wetherby Wealth Management
California
$356K -$1.63K -200 -0.5%
Creative Planning
86
Creative Planning
Kansas
$338K – – –
TI
87
Trexquant Investment
Connecticut
$329K +$317K +39,000 New
SCM
88
Stevens Capital Management
Pennsylvania
$309K +$298K +36,630 New
AIM
89
ARGA Investment Management
Connecticut
$303K +$293K +36,000 New
DTL
90
Dynamic Technology Lab
Singapore
$286K +$276K +34,000 New
Neuberger Berman Group
91
Neuberger Berman Group
New York
$282K -$97.2K -11,950 -26%
QI
92
QS Investors
New York
$282K – – –
Grantham, Mayo, Van Otterloo & Co (GMO)
93
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$282K +$272K +33,500 New
WS
94
Wedbush Securities
California
$274K – – –
Wolverine Trading
95
Wolverine Trading
Illinois
$252K +$250K +30,695 New
DekaBank Deutsche Girozentrale
96
DekaBank Deutsche Girozentrale
Germany
$237K +$234K +28,800 New
AL
97
Airain Ltd
Guernsey
$223K +$215K +26,405 New
SG Americas Securities
98
SG Americas Securities
New York
$144K +$139K +17,085 New
SLI
99
Sumitomo Life Insurance
Japan
$101K -$73.2K -9,000 -43%
CAW
100
Cornerstone Advisors (Washington)
Washington
$79K +$73.8K +9,075 +3,129%
2 3
4
5 6

RDY Hedge Fund Activity: Q2 2017 in Review

128 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2017, worth a combined $1.07B — up 6.1% from $1B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of RDY and 13 opened new positions — a net loss of 6 holders — while 46 trimmed existing stakes and 42 added.

The largest buyer was Royal Bank of Canada, adding an estimated $36.3M. The largest seller was AQR Capital Management, cutting an estimated $20M.

  • 128 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2017, down from 134 in Q1 2017.
  • Funds reported $1.07B of Dr. Reddy's Laboratories stock for Q2 2017, up 6.1% quarter-over-quarter.
  • 13 funds opened new Dr. Reddy's Laboratories positions in Q2 2017 and 19 closed out, a net change of -6 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q2 2017 was Royal Bank of Canada, an estimated $36.3M added.
  • The largest Dr. Reddy's Laboratories seller in Q2 2017 was AQR Capital Management, an estimated $20M sold.

Based on aggregated 13F filings for Q2 2017.